Glibenclamide Chemical is used as pharmaceutical excipient to treat diabetes mellitus ( for patients who are not dependent on insulin), especially in cats. As sulfonylurea oral hypoglycemic factor, this chemical is instrumental in raising insulin secretion from pancreas. This chemical affects functioning of sulponylurea receptors on beta cells of pancreas and enhances sensitivity of its insulin receptors. Medicine formulated from Glibenclamide Chemical has slight solubility in water. Its composition is easily absorbed by gastrointestinal tract of human body. Composition of this pharmaceutical chemical is FDA approved.
Developed and Managed by Infocom Network Private Limited.